J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Navab, M.
Right arrow Articles by Fogelman, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Navab, M.
Right arrow Articles by Fogelman, A. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 42, 1308-1317, August 2001
Copyright © 2001 by Lipid Research, Inc.


Methods

A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids

Mohamad Navaba, Susan Y. Hamaa, Greg P. Hougha, Ganesamoorthy Subbanagoundera, Srinivasa T. Reddya, and Alan M. Fogelmana
a Atherosclerosis Research Unit, Division of Cardiology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA 90095

Correspondence to: Mohamad Navab, To whom correspondence should be addressed., mnavab{at}mednet.ucla.edu (E-mail)

We have developed a novel and rapid cell-free assay of the ability of HDL to prevent the formation of or inactivate oxidized phospholipids. HDL was tested for its ability to inhibit the oxidation of LDL, or inhibit the oxidation of L-{alpha}-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine (PAPC) by hydroperoxyoctadecadienoic acid (HPODE), or inactivate oxidized PAPC (Ox-PAPC). In each case the fluorescent signal generated in the presence of the test substances and the test HDL was determined. As little as 2.5 µg of normal human HDL cholesterol significantly inhibited the fluorescent signal generated by Ox-PAPC; results did not differ regardless of whether the HDL was prepared by gel electrophoresis, fast protein liquid chromatography, or dextran sulfate precipitation. HDL from each of 27 patients with coronary atherosclerosis failed to inhibit the fluorescent signal generated by a control LDL, whereas HDL from each of 31 matched normal subjects with the same levels of HDL cholesterol significantly inhibited the signal. Results from an established cell-based assay (Navab, M., S. Hama, J. Cooke, G. M. Anantharamaiah, M. Chaddha, L. Jin, G. Subbanagounder, K. F. Faull, S. T. Reddy, N. E. Miller, and A. M. Fogelman. 2000. J. Lipid Res. 41: 1481;–1494) were identical. HDL from the patients also failed to inhibit the fluorescent signal generated from PAPC plus HPODE (10 of 10 patients) whereas HDL from matched controls (8 of 8 patients) significantly inhibited the fluorescent signal.

We conclude that this new assay has the potential to allow widespread testing of the hypothesis that HDL that is dysfunctional in preventing the formation or inactivating oxidized phospholipids may play an important role in the development of athero-sclerosis. — Navab, M., S. Y. Hama, G. P. Hough, G. Subbanagounder, S. T. Reddy, and A. M. Fogelman. A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids. J. Lipid Res. 2001. 42: 1308;–1317.

Supplementary key words: LDL, mildly oxidized LDL, HPODE, HPETE, atherosclerosis


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
H. Zhou, K. C. Tan, S. W. Shiu, and Y. Wong
Reply
Nephrol. Dial. Transplant., August 1, 2008; 23(8): 2700 - 2700.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. M. deGoma, R. L. deGoma, and D. J. Rader
Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches.
J. Am. Coll. Cardiol., June 10, 2008; 51(23): 2199 - 2211.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
L. T. Bloedon, R. Dunbar, D. Duffy, P. Pinell-Salles, R. Norris, B. J. DeGroot, R. Movva, M. Navab, A. M. Fogelman, and D. J. Rader
Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients
J. Lipid Res., June 1, 2008; 49(6): 1344 - 1352.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
R. Movva and D. J. Rader
Laboratory Assessment of HDL Heterogeneity and Function
Clin. Chem., May 1, 2008; 54(5): 788 - 800.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. A. Araujo, B. Barajas, M. Kleinman, X. Wang, B. J. Bennett, K. W. Gong, M. Navab, J. Harkema, C. Sioutas, A. J. Lusis, et al.
Ambient Particulate Pollutants in the Ultrafine Range Promote Early Atherosclerosis and Systemic Oxidative Stress
Circ. Res., March 14, 2008; 102(5): 589 - 596.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
S. I. van Leuven, R. Hezemans, J. H. Levels, S. Snoek, P. C. Stokkers, G. K. Hovingh, J. J. P. Kastelein, E. S. Stroes, E. de Groot, and D. W. Hommes
Enhanced atherogenesis and altered high density lipoprotein in patients with Crohn's disease
J. Lipid Res., December 1, 2007; 48(12): 2640 - 2646.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
B. J. Van Lenten, A. C. Wagner, M. Navab, G. M. Anantharamaiah, S. Hama, S. T. Reddy, and A. M. Fogelman
Lipoprotein inflammatory properties and serum amyloid A levels but not cholesterol levels predict lesion area in cholesterol-fed rabbits
J. Lipid Res., November 1, 2007; 48(11): 2344 - 2353.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Weihrauch, H. Xu, Y. Shi, J. Wang, J. Brien, D. W. Jones, S. Kaul, R. A. Komorowski, M. E. Csuka, K. T. Oldham, et al.
Effects of D-4F on vasodilation, oxidative stress, angiostatin, myocardial inflammation, and angiogenic potential in tight-skin mice
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1432 - H1441.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Watanabe, K. J. Chou, J. C. Liao, Y. Miao, H.-H. Meng, H. Ge, V. Grijalva, S. Hama, K. Kozak, G. Buga, et al.
Differential Association of Hemoglobin with Proinflammatory High Density Lipoproteins in Atherogenic/Hyperlipidemic Mice: A NOVEL BIOMARKER OF ATHEROSCLEROSIS
J. Biol. Chem., August 10, 2007; 282(32): 23698 - 23707.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
N. Sanossian, J. L. Saver, M. Navab, and B. Ovbiagele
High-Density Lipoprotein Cholesterol: An Emerging Target for Stroke Treatment
Stroke, March 1, 2007; 38(3): 1104 - 1109.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
C. K. Roberts, C. Ng, S. Hama, A. J. Eliseo, and R. J. Barnard
Effect of a short-term diet and exercise intervention on inflammatory/anti-inflammatory properties of HDL in overweight/obese men with cardiovascular risk factors
J Appl Physiol, December 1, 2006; 101(6): 1727 - 1732.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Baldan, L. Pei, R. Lee, P. Tarr, R. K. Tangirala, M. M. Weinstein, J. Frank, A. C. Li, P. Tontonoz, and P. A. Edwards
Impaired Development of Atherosclerosis in Hyperlipidemic Ldlr-/- and ApoE-/- Mice Transplanted With Abcg1-/- Bone Marrow
Arterioscler. Thromb. Vasc. Biol., October 1, 2006; 26(10): 2301 - 2307.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
A. Kontush and M. J. Chapman
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
Pharmacol. Rev., September 1, 2006; 58(3): 342 - 374.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
S. Acin, M. A. Navarro, J. M. Arbones-Mainar, N. Guillen, A. J. Sarria, R. Carnicer, J. C. Surra, I. Orman, J. C. Segovia, R. d. l. Torre, et al.
Hydroxytyrosol Administration Enhances Atherosclerotic Lesion Development in Apo E Deficient Mice
J. Biochem., September 1, 2006; 140(3): 383 - 391.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Ou, J. Wang, H. Xu, Z. Ou, M. G. Sorci-Thomas, D. W. Jones, P. Signorino, J. C. Densmore, S. Kaul, K. T. Oldham, et al.
Effects of D-4F on Vasodilation and Vessel Wall Thickness in Hypercholesterolemic LDL Receptor-Null and LDL Receptor/Apolipoprotein A-I Double-Knockout Mice on Western Diet
Circ. Res., November 25, 2005; 97(11): 1190 - 1197.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
B. Lohrke, T. Viergutz, W. Kanitz, B. Losand, D. G. Weiss, and M. Simko
Short Communication: Hydroperoxides in Circulating Lipids from Dairy Cows: Implications for Bioactivity of Endogenous-Oxidized Lipids
J Dairy Sci, May 1, 2005; 88(5): 1708 - 1710.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
P. O. Kwiterovich Jr, S. L. Cockrill, D. G. Virgil, E. S. Garrett, J. Otvos, C. Knight-Gibson, P. Alaupovic, T. Forte, L. Zhang, Z. N. Farwig, et al.
A Large High-Density Lipoprotein Enriched in Apolipoprotein C-I: A Novel Biochemical Marker in Infants of Lower Birth Weight and Younger Gestational Age
JAMA, April 20, 2005; 293(15): 1891 - 1899.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. S. Forrester, R. Makkar, and P.K. Shah
Increasing High-Density Lipoprotein Cholesterol in Dyslipidemia by Cholesteryl Ester Transfer Protein Inhibition: An Update for Clinicians
Circulation, April 12, 2005; 111(14): 1847 - 1854.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. J. Barter, S. Nicholls, K.-A. Rye, G.M. Anantharamaiah, M. Navab, and A. M. Fogelman
Antiinflammatory Properties of HDL
Circ. Res., October 15, 2004; 95(8): 764 - 772.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
V. Ribas, J. L. Sanchez-Quesada, R. Anton, M. Camacho, J. Julve, J. C. Escola-Gil, L. Vila, J. Ordonez-Llanos, and F. Blanco-Vaca
Human Apolipoprotein A-II Enrichment Displaces Paraoxonase From HDL and Impairs Its Antioxidant Properties: A New Mechanism Linking HDL Protein Composition and Antiatherogenic Potential
Circ. Res., October 15, 2004; 95(8): 789 - 797.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
D. Yan, M. Navab, C. Bruce, A. M. Fogelman, and X.-C. Jiang
PLTP deficiency improves the anti-inflammatory properties of HDL and reduces the ability of LDL to induce monocyte chemotactic activity
J. Lipid Res., October 1, 2004; 45(10): 1852 - 1858.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Navab, G.M. Anantharamaiah, S. T. Reddy, S. Hama, G. Hough, V. R. Grijalva, A. C. Wagner, J. S. Frank, G. Datta, D. Garber, et al.
Oral D-4F Causes Formation of Pre-{beta} High-Density Lipoprotein and Improves High-Density Lipoprotein-Mediated Cholesterol Efflux and Reverse Cholesterol Transport From Macrophages in Apolipoprotein E-Null Mice
Circulation, June 29, 2004; 109(25): 3215 - 3220.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. Navab, G. M. Ananthramaiah, S. T. Reddy, B. J. Van Lenten, B. J. Ansell, G. C. Fonarow, K. Vahabzadeh, S. Hama, G. Hough, N. Kamranpour, et al.
Thematic review series: The Pathogenesis of Atherosclerosis The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL
J. Lipid Res., June 1, 2004; 45(6): 993 - 1007.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
D. Colquhoun, A. Keech, D. Hunt, I. Marschner, J. Simes, P. Glasziou, H. White, P. Barter, A. Tonkin, and for the LIPID Study Investigators
Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study
Eur. Heart J., May 1, 2004; 25(9): 771 - 777.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
W. H. F. Sutherland, S. A. de Jong, and R. J. Walker
Hypochlorous acid and low serum paraoxonase activity in haemodialysis patients: an in vitro study
Nephrol. Dial. Transplant., January 1, 2004; 19(1): 75 - 82.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Navab, S. Hama, G. Hough, and A. M. Fogelman
Oral Synthetic Phospholipid (DMPC) Raises High-Density Lipoprotein Cholesterol Levels, Improves High-Density Lipoprotein Function, and Markedly Reduces Atherosclerosis in Apolipoprotein E-Null Mice
Circulation, October 7, 2003; 108(14): 1735 - 1739.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Navab, G.M. Anantharamaiah, S. Hama, D. W. Garber, M. Chaddha, G. Hough, R. Lallone, and A. M. Fogelman
Oral Administration of an Apo A-I Mimetic Peptide Synthesized From D-Amino Acids Dramatically Reduces Atherosclerosis in Mice Independent of Plasma Cholesterol
Circulation, January 22, 2002; 105(3): 290 - 292.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Navab, B. J. Van Lenten, S. T. Reddy, and A. M. Fogelman
High-Density Lipoprotein and the Dynamics of Atherosclerotic Lesions
Circulation, November 13, 2001; 104(20): 2386 - 2387.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.